Health Care/Hospital
Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores
NANPING, China, Nov. 16, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company's experience stores started offering Coenzyme Q10 - a best-selling product from ...
2020-11-16 21:00
2950
PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020
DAEJEON, South Korea, Nov. 16, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) announced today that the company will present the final results of the Phase IIa clinical trial of Olinvacimab for rGBM (recurrent glioblastoma multiforme) patients at SNO (Society of Neuro-Oncology) 2020. ...
2020-11-16 21:00
1257
Viatris Inc. Launches as a New Kind of Healthcare Company, Positioned to Meet the World's Evolving Healthcare Needs
PITTSBURGH, Nov. 16, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) launched today following the successful combination of Mylan N.V. and Pfizer's Upjohn business. By combining these two complementary legacy companies, Viatris has the scientific, manufacturing and distribution expertise with pr...
2020-11-16 20:30
1477
Harbour BioMed Will Present Results From Its Phase II Clinical Trial with Tanfanercept (HBM9036) in Patients with Moderate-to-Severe Dry Eye Disease in China at the 25th Congress of Chinese Ophthalmological Society
SUZHOU, China, Nov. 16, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, bio-pharmaceutical company today announced that the company will present the phase II clinical trial results of Tanfanercept (HBM9036) at the 25th Congress of Chinese Ophthalmological Society (CCOS) held ...
2020-11-16 20:17
2871
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense
PLYMOUTH MEETING, Pa., Nov. 16, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that it has received clearance from the U.S. Food & Dru...
2020-11-16 20:00
3486
KPCPEN Introduces Two Paediatric Professors to Accelerate the Preparation of COVID-19 Vaccine
JAKARTA, Indonesia, Nov. 16, 2020 /PRNewswire/ -- The government through Covid-19 Handling and National Economic Recovery Committee (KPCPEN) continues its various efforts in handling the pandemic as well as bringing economic relief inIndonesia. In its efforts to progress the COVID-19 vaccine, ...
2020-11-16 16:46
1776
Gilead Sciences Announces Recipients of its First Asia HIV Research Scholar Program
HONG KONG, Nov. 16, 2020 /PRNewswire/ -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the recipients of its first Asia HIV Research Scholar Program ("Program"). The Program awards up toUS$130,000 over a period of two years to support innovative HIV scientific research led by early-career ...
2020-11-16 15:02
3733
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate
* Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials * Cytiva provides FlexFactory™ bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market SHANGHAI, Nov. 16, 2020 /PRNewsw...
2020-11-16 14:00
1358
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
SAN FRANCISCO and SUZHOU, China, Nov. 16, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2020-11-16 08:00
5274
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19
– Oral treatment with novel dual-mechanism of action has the potential to address the two critical elements of COVID-19: viral replication and uncontrolled inflammatory response – – Randomized, double-blind, placebo-controlled, Phase 2/3 clinical study with two stages initiated at several sites ...
2020-11-16 05:00
1416
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center
WUXI, China, Nov. 13, 2020 /PRNewswire/ -- Wuxi Biortus Biosciences Co. Ltd. ("Biortus"), a global leader in structural biology service for drug discovery, recently closed round A financing withUS$15 million investment led by Bayland Capital, and the fund will be used to establish a global cryo-E...
2020-11-14 12:40
8514
International Diabetes Federation calls for improved funding and training to help nurses tackle the global diabetes crisis
IDF marks World Diabetes Day and the International Year of the Nurse and Midwife by offering free accredited diabetes training BRUSSELS, Nov. 14, 2020 /PRNewswire/ -- This World Diabetes Day, the International Diabetes Federation (IDF) is calling for more nurses to be trained to help people livi...
2020-11-14 08:00
3559
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results
HAIKOU, China, Nov. 13, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...
2020-11-14 05:10
8271
The third CIIE concludes, $72.6 billion in intended deals for the coming year inked
SHANGHAI, Nov. 14, 2020 /PRNewswire/ -- Despite the global market uncertainties caused by the COVID-19 pandemic, the confidence and interest that foreign companies have in the Chinese market appear unchanged, with the value of tentative deals reached for one-year purchases of goods and services a...
2020-11-14 03:21
5120
CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN If approved by the European Commission, ELZONRIS will be the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, inEurope FLORENCE, Italy, Nov. 14...
2020-11-14 01:03
4009
FDI World Dental Federation: Study shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year
FDI World Dental Federation (FDI) releases new White Paper on antibiotic resistance to mark World Antimicrobial Awareness Week GENEVA and LONDON, Nov. 14, 2020 /PRNewswire/ -- One of the unintended consequences of the COVID-19 lockdowns inEngland earlier this year has been a 25 per cent increase...
2020-11-14 01:00
3795
China Jo-Jo Drugstores Reports Second Quarter 2021 Financial Results
HANGZHOU, China, Nov. 13, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced its finan...
2020-11-13 22:00
7986
China Biologic Products to Report Third Quarter 2020 Financial Results
BEIJING, Nov. 13, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its third quarter 2020 financial results o...
2020-11-13 21:00
7382
The fourth CIIE begins taking stall reservations from exhibitors
SHANGHAI, Nov. 13, 2020 /PRNewswire/ -- Some exhibitors planning to attend the fourth China International Import Expo (CIIE) next year started to reserve their stalls onNov 8. This is the first time that the CIIE has offered such an option. Five dairy companies – Fonterra, Mille, Ausnutria, Yash...
2020-11-13 21:00
3862
AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting
VEVEY, Switzerland, Nov. 13, 2020 /PRNewswire/ -- On November 13th, 2020,
AlpVision is launching the "AlpVision COVID-19 Initiative" helping
pharmaceutical companies to protect COVID-19 relevant medicines against
counterfeiting.
2020-11-13 20:25
2791
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 287 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7877
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6967
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4260
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2910